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Abstract  
Objectives: to test whether or not chemical and/or physical modifications of polyethylene glycol 
(PEG) hydrogels influence degradation time, matrix/membrane stability and integration into 
surrounding hard and soft tissues. 
Materials and methods: In 28 rabbits, six treatment modalities were randomly applied to 6 
sites on the rabbit skull: a dense network PEG hydrogel (PEG HD), a medium-dense network 
PEG hydrogel (PEG MD), a medium-dense network PEG hydrogel modified with an RGD 
sequence (PEG MD/RGD), a medium-dense network PEG hydrogel modified with RGD with 
reduced carboxymethyl cellulose (PEG MD/RGD_LV), a loose network PEG hydrogel modified 
with RGD (PEG LD/RGD) and a collagen membrane (BG). Descriptive histology and 
histomorphometry were performed at 1, 2, 4 and 6 weeks.  
Results: PEG HD revealed the highest percentage of residual matrix at all time-points starting 
with 47.2% (95% CI: 32.8%-63.8%) at 1 week and ending with 23.4% (95% CI: 10.3%-
49.8%) at 6 weeks. The hydrogel with the loosest network (PEG LD/RGD) was stable the first 
two weeks and then degraded continuously with a final area of 8.3% (95% CI: 3.2%-21.2%). 
PEG HD was the most stable and densely stained membrane, whereas PEG MD and PEG LD 
matrices integrated faster, but started to degrade to a higher degree between 2 and 4 weeks. 
PEG MD degradation was dependent on the addition of RGD and the amount of CMC. 
Conclusions: Chemical and/or physical modifications of PEG hydrogels influenced matrix 
stability. PEG MD/RGD demonstrated an optimal balance between degradation time and 
integration into the surrounding soft and hard tissues. 
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Introduction 
Various guided bone regeneration (GBR) membranes were evaluated in the past to fulfill the 
clinician’s needs. Non-resorbable membranes are documented to have long-term clinical success 
and were considered the gold standard in GBR procedures for many years (Benic and Hammerle, 
2014). However, they are associated with multiple disadvantages including the need for removal 
at second stage and reveal a relatively high risk for soft tissue dehiscence. In order to overcome 
these issues, resorbable membranes made of native collagen were developed and presented 
similar long-term outcomes based on clinical studies (Jung et al., 2013). The lack of space-
maintenance and the need for a more time-consuming membrane shaping and adapting during 
surgery, led to the development of alternative materials, including the use of polyethylene 
hydrogels (PEGs). PEG hydrogels were used for various indications ranging from a biodegradable 
membrane for GBR (Jung et al., 2006; Jung et al., 2009a; Jung et al., 2009b), to a matrix for 
bone regeneration and to the use as a carrier for biologic mediators (Jung et al., 2007a; Jung et 
al., 2007b; Jung et al., 2008). When applied as a GBR membrane, clinical data demonstrated 
success up to 5 years, but shortcomings in terms of the initial soft tissue attachment, which in 
some cases led to transient soft tissue complications (Jung et al., 2015; Ramel et al., 2012). In 
order to facilitate cell attachment and reduce the number of early complications, modifications of 
the PEG hydrogels were evaluated. This included physical (changes in the network structure) and 
chemical modifications (addition of a bioadhesive motif like the Arginine-Glycine-Aspartic acid 
(RGD) for an improved cell adhesion and modifications of the viscosity by controlling the amount 
of carboxymethyl cellulose (CMC) (Dettin et al., 2005; Halstenberg et al., 2002; Park et al., 
2004; Park et al., 2005; Shu et al., 2004). Preclinical data in rabbits and mini-pigs using various 
PEG hydrogels demonstrated that such modified hydrogels might lead to an increasing bone 
formation when RGD was added, associated with a relatively low stability and an enhanced turn-
over of the hydrogel (Thoma et al., 2011; Thoma et al., 2014). From a clinical point of view, 
when used as a GBR membrane, an optimal balance between an enhanced bone formation and 
long-term space-maintenance needs to be found. In order to validate the results from previous 
preclinical studies and to evaluate the influence of chemical and physical modifications of PEG 
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hydrogels at relatively early healing time-points, the present study was designed. The aim of the 
present study was, therefore, to test whether or not the chemical and/or physical modifications 
of PEG hydrogels influence degradation time, matrix stability and soft and hard tissue integration 
in a rabbit cranial model. 
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Materials and methods 
Animals 
The present experimental protocol was approved by the Animal Research Ethics Committee at the 
University of Zurich, Switzerland prior to the start of the study. In total, 28 adult (12 months old) New 
Zealand white rabbits, weighing between 3 and 4 kg were included. All animals were kept in a purpose-
designed room for experimental animals and were fed a standard laboratory diet during the entire study 
period.  
 
Surgical procedure 
The protocol of the present study has already been described in detail (Thoma et al., 2011). In brief, 
anesthesia for the animals was initiated by injection of 65 mg/kg of ketamine and 4 mg/kg of xylazine 
and maintained with Isofluoran/O2 (Aerane, Ohmeda Carbide Inc., Liberty Corner, NJ, USA). 
Subsequently, the surgical area was shaved and disinfected with iodophor for aseptic surgical 
conditions. Following a straight incision from the nasal bone to the midsagittal crest, the soft tissues 
including the periosteum were elevated (Fig. 1a). In order to simplify the histologic preparation, nine 
titanium pins (Frios®, Dentsply Friadent, Mannheim, Germany) were placed, three at the mid-sagittal 
line and 6 laterally to the mid-sagittal line (Fig. 1b). In addition, linear bony defects were prepared 
using a small round bur (diameter 0.7mm) between the reference pins at the mid-sagittal line and the 
pins on the left and right sides (Fig. 1b). 
The following six treatment modalities were then randomly assigned to the six sites (Fig. 1 c-f): 
1. a dense network PEG hydrogel (PEG HD) (MembraGel®, Institut Straumann AG, Basel, Switzerland) 
2. a medium-dense network PEG hydrogel (PEG MD) (Institut Straumann AG, Basel, Switzerland) 
3. a medium-dense network PEG hydrogel modified with RGD (PEG MD/RGD) (Institut Straumann AG, 
Basel, Switzerland) 
4. a medium-dense network PEG hydrogel modified with RGD without addition of CMC and according 
low viscosity (PEG MD/RGD_LV) (Institut Straumann AG, Basel, Switzerland) 
5. a loose network PEG hydrogel modified with RGD (PEG LD/RGD) (Institut Straumann AG, Basel, 
Switzerland) 
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6. a collagen membrane (BG) (BioGide®,Geistlich Pharma, Wolhusen, Switzerland) 
The preparation of the hydrogels has been described in previous publications (Thoma et al., 2011; 
Thoma et al., 2014). In brief, the PEG hydrogels were prepared by mixing a multi-arm PEG with thiol 
end groups and a multi-arm PEG with acrylate end groups in an aqueous buffer system 
(triethanolamine/HCl) at physiological pH. Carboxymethyl cellulose (CMC) was added as a viscosity 
modifier to the buffer solutions to control the flow properties of the PEG solutions. For preparing the 
RGD containing PEG hydrogels (PEG MD/RGD; PEG MD/RG_LV; PEG LD/RDG), a peptide containing an 
integrin-binding RGD for cell adhesion was used and a cysteine group for connecting the peptide to a 
PEG-acrylate terminus. All in situ gelling PEG hydrogels were applied from a mixing syringe as a liquid 
over the bone. In order to standardize the hydrogel thickness to 1.5mm, preformed templates were 
placed on the bone and removed after the gelling process of the hydrogels (Fig. 1c). The BG 
membranes were trimmed to a rectangular shape and placed on the skull without fixation (Fig. 1b). 
Following the removal of the periosteum primary wound closure was obtained. The animals were 
sedated with barbiturates at 1 (n=7), 2 (n=7), 4 (n=7), and 6 weeks (n=7) and sacrificed with an 
overdose of Ketamine. 
 
Histological preparation  
All specimens were placed in a mixture of 2.5% glutaraldehyde, 2% paraformaldehyde, and 0.025% 
CaCl in 0.02 M Na-cacodylate buffer. Following fixation the tissue specimens were washed in 0.185 M 
Na-cacodylate buffer and radiographed to determine the exact cutting planes parallel and on the left 
and right side of the sagittal suture. The tissue blocks were then sectioned with a band-saw (EXAKT, 
Norderstedt, Germany) and postfixed in 1.33% OsO4 buffered with 0.067 M s-collidine. Following an 
overnight wash in 0.185 M Na-cacodylate buffer, the specimens were dehydrated in ascending grades 
of alcohol and embedded in pure Epon. Three slices of about 1 mm in thickness were cut from each site 
and glued on empty Epon cylinders. The block-size was adjusted to include the full anteroposterior 
extension of the membranes. Finally, sections of 80 µm in thickness were cut with a microtome 
(Reichert Ultracut E microtome, Leica Microsystems, Heerbrugg, Switzerland) and stained with toluidine 
blue or periodic acid-Schiff (PAS) and methylene blue-Azur II. 
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Descriptive histologic and histomorphometric analyses 
The histological samples were digitized using a stereoscope (Nikon Eclipse 90i, Nikon, Egg, 
Switzerland). For descriptive histologic analysis, the following parameters were analyzed: (i) form and 
appearance of the hydrogel/membrane, (ii) the interface between the connective tissue and the 
hydrogel/membrane, (iii) the interface between the hydrogel/membrane and the native bone, (iv) new 
bone formation surrounding and/or within the hydrogel/membrane, and (v) the inflammatory response. 
For histomorphometric analysis, the images were analyzed using an image-processing program 
(Image J, NIH, Bethesda, USA). A standardized region of interest (ROI) was chosen extending 
from the bone defect into the soft tissue (Fig. 2a). The following parameters were calculated 
within the ROI: (i) new bone, (ii) old bone, iii) non-mineralized tissue, (iv) matrix/membrane, 
and (v) background space. Two masked experienced examiners independently performed all the 
measurements. 
 
Statistical analysis 
All measured outcomes were summarized as means and standard deviations, and as medians 
and interquartile ranges. Mixed linear models were performed using the non-parametric 
Brunner-Langer method (Brunner and Langer, 1999). The level of significance was set at 
p<0.05. Results from the models are expressed as adjusted ‘means’. Further details are 
provided in the appendix. 
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Results 
All rabbits were healthy during the entire study period and neither systemic nor local adverse 
events were observed. 
 
Descriptive histology 
PEG HD  
The PEG dense network hydrogel was intensely stained, had a semilunar shape and maintained 
the space up to the last sacrifice time-point (6 weeks). At 1 and 2 weeks, the hydrogel surface 
was smooth with few irregularities. An empty space surrounded the PEG network. At 4 weeks, 
the contact to the underlying bone and the subcutaneous soft tissue was more intimate. This 
observation was even more obvious at 6 weeks (Fig. 2b), demonstrating no empty space 
surrounding the PEG, but a close contact with the surrounding soft and hard tissues. Overall, 
only limited bone formation was observed underneath the hydrogel. 
PEG MD  
The PEG MD hydrogel was slightly stained and appeared to maintain the space up to 2 weeks 
(Fig. 2c). Degradation and remodeling processes started after 2 weeks and continued up to 6 
weeks. An empty space between the membrane and the soft tissues was present during the first 
2 weeks and disappeared gradually at 4 and 6 weeks.  At the later time-points only few 
remnants could be identified within a newly formed connective tissues. Bone formation was 
limited and predominantly occurred underneath the hydrogel on top of the created defect.  
PEG MD/RGD  
The hydrogel was densely stained at 1 and 2 weeks. The borders of the hydrogel were in 
intimate contact with the surrounding connective tissue (Fig. 2d). The shape of the original 
hydrogel space was not maintained during 6 weeks. Mainly between 2 and 4 weeks, the 
hydrogel appeared to have collapsed and remodeled. At 4 and 6 weeks, only remnants 
surrounded by connective tissue were identified. The hydrogel remnants were still densely 
stained without a clear distinction to the covering soft tissue and the underlying bone. 
PEG MD/RGD_LV 
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The hydrogel was predominantly visible at 1 and 2 weeks. At these time-points, the space 
appeared to have been maintained and the hydrogel appeared to be intact. At 2 weeks, an 
empty space surrounded the PEG hydrogel, swelling and subsequent shrinkage had taken place. 
The borders of the hydrogel were distinct towards the covering soft tissues. The contact to the 
underlying bone was intimate with some limited bone formation visible at 2 weeks already. At 4 
and 6 weeks, the space was still maintained, but connective tissue formation had taken place 
and started to replace this space, originally maintained by the hydrogel. The formation of new 
connective tissue was predominantly visible at 6 weeks.  
PEG LD/RGD  
The bulk of the looser network PEG-RGD network was intensively stained at 1 and 2 weeks. At 
these time-points, a small space surrounded the hydrogel, but less distinct than in the PEG HD 
and PEG MD groups. The border at 1 week was distinct and had only few irregularities (Fig. 2e), 
whereas at 2 weeks, the hydrogel had a more intimate contact with the surrounding tissues. At 
4 and 6 weeks, no remnants of the hydrogel were observed. At 6 weeks, new bone and 
connective tissue formation had taken place and replaced most of the space originally 
maintained by the hydrogel. Bone formation was predominantly visible at 6 weeks, and mainly 
occurred within and on top of the created defect. 
BG  
The collagen membrane appeared to have maintained the shape and was in close contact to the 
underlying bone and the covering soft tissue already at 1 week (Fig. 2f). The bulk of the 
membrane was dominated with thick collagen fibers. At 4 and 6 weeks, the remodeling 
processes within the membrane and on the membrane’s surface, made it difficult to clearly 
differentiate it from the surrounding tissues.  
 
Histomorphometric measurements 
All summarized data are shown in table 1. The histomorphometric analysis revealed only 
minimal, but increasing new bone formation over the course of 6 weeks for all 
matrices/membranes. At 6 weeks, the largest adjusted mean amount of newly formed bone (% 
area within the ROI) was observed for PEG MD 2.4% (95% CI: 0.9%-10.3%) followed by BG 
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2.3% (95% CI: 0.9%-8.7%) and by PEG HD 2.1% (95% CI: 0.7%-4.8%). None of the 
differences between the 6 groups were statistically significant at any time-point (p>0.05), 
except between BG and PEG HD at 1 week, favoring BG (p=0.024). In terms of residual 
matrix/membrane, individual differences between the matrices/membranes were observed (Fig. 
3). The largest adjusted mean area was calculated for PEG MD/RGD 61.0% (95% CI: 43.2%-
73.9%) and PEG HD 47.2% (95% CI: 32.8%-63.8%) at 1 week, and at 6 weeks for PEG HD 
23.4% (95% CI: 10.3%-49.8%) followed by PEG MD/RGD 17.1% (95% CI: 6.5%-30.0%). PEG 
HD revealed high values of residual matrix at all time-points starting with 47.2% (95% CI: 
32.8%-63.8%) at 1 week and ending with 23.4% (95% CI: 10.3%-49.8%) at 6 weeks. PEG MD 
degradation was dependent on the addition of RGD and the amount of CMC. The adjusted mean 
matrix area for PEG MD/RGD_LV demonstrated an increase between the first week with 22.5% 
(95% CI: 17.0%-42.8%), to the second and fourth week with 40.9% (95% CI: 30.7%-59.3%) 
and 36.8% (95% CI: 18.8%-67.2%), respectively, but then a decrease to 8.3% (95% CI: 
3.9%-21.0%) at 6 weeks. The hydrogel with the loosest network (PEG LD/RGD) was stable the 
first two weeks and then decreased continuously in its dimension with a final area of 8.3% (95% 
CI: 3.2%-21.0%). The collagen membrane (BG) revealed a continuous degradation over time 
with 21.2% (95% CI: 15.9%-37.0%) at 1 week and 8.5% (95% CI: 3.2%-21.9%) at 6 weeks. 
The differences between PEG MD/RGD and PEG MD/RGD_LV (p=0.016), PEG LD/RGD 
(p=0.022), and BG (p=0.009) were statistically significant at 1 week. At 4 weeks, the 
differences between PEG HD and BG (p=0.006), PEG LD/RGD (p=0.028), PEG MD/RGD 
(p=0.004) were statistically significant. All other comparisons between the groups did not reveal 
statistically significant differences at any time-point (p>0.05). Comparisons of these outcomes 
at 1 week and 6 weeks are shown in figure 1 in the appendix. 
The p-values for the global comparison for the factors treatment, time point and interaction of 
treatment by time point when the outcome was the matrix/membrane were p<0.0001, p<0.001 
and p=0.033 respectively. This result reflects observations from figure 3. Results for all global 
comparisons are given in table 1 in the appendix. 
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Discussion 
The present experimental study revealed based on histomorphometric measurements that 
chemical and/or physical modifications of PEG hydrogels predominantly influenced matrix 
stability and degradation time. This was demonstrated by i) the dense network PEG hydrogel 
(PEG HD) being almost stable over time, ii) the mid-range dense PEG hydrogel (PEG MD) being 
stable up to 4 weeks and then degrading slightly over time and, iii) the loose network PEG 
hydrogel (PEG LD) degradation to the highest extent after being stable for 2 weeks. In addition, 
modifications of PEG MD seemed to change the characteristics of degradation within the first four 
weeks. 
The dense network PEG hydrogel (PEG HD) was the most stable material in terms of degradation 
time and volume maintenance. This was predominantly demonstrated by maintaining a 
semilunar shape over the entire study period. This type of hydrogel membrane has been 
evaluated in various preclinical and clinical studies for a number of indications (Jung et al., 2006; 
Jung et al., 2009a; Jung et al., 2009b), and also for basic requirements of GBR membranes such 
as a barrier function and cell occlusiveness. In an experimental study in rats, using a 
subcutaneous pouch model, PEG HD demonstrated a barrier function up to 6 months and cell 
occlusiveness up to 4 months (Wechsler et al., 2008). These long-term data are supported by 
the present study demonstrating the same membrane stability with a minimal decrease in 
thickness over time. This long-term stability might be due to the high network density, which 
may further explain the observed cell occlusiveness of up to 4 months (Wechsler et al., 2008). 
As reported earlier, one of the basic principles of GBR is space maintenance, but at the same 
time, a barrier membrane needs to be semi-permeable. The PEG HD membrane appears to have 
a rather strict cell occlusiveness. This is underlined by findings of the present study that showed 
a clear and distinct border towards the covering soft tissues. A close and more intimate contact 
was only observed at 4 weeks in this rabbit model. This histologic finding, clinically translated 
into a lack of an attachment between the barrier membrane and the covering soft tissue flap, 
may in part be responsible for a relatively high rate of early wound dehiscences (Jung et al., 
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2009a). In order to overcome such clinical difficulties, the option exists to modify the existing 
hydrogels. One of the options is to reduce the network density. Such a network might allow an 
earlier ingrowth of connective tissue. In the present study, three groups of a mid-range dense 
network PEG hydrogel (PEG MD) were tested. The native PEG MD demonstrated a reduced 
stability occupying a smaller area on top of the rabbit skull up to 4 weeks. Between 4 and 6 
weeks, matrix/membrane degradation was highly increased. However, even with PEG MD, 2 
weeks were needed until the empty space between the soft tissues and the hydrogel started to 
disappear and a more intimate contact was obtained. 
Apart from changing the hydrogel network, the addition of an RGD sequence has been shown to 
improve the contact between membranes and soft tissues at week one and two. Furthermore, 
the degradation seems to be accelerated by RGD between two and four weeks as shown by PEG 
MD/RGD when compared to the native PEG MD. The properties of hydrogels with RGD regarding 
degradation and contact to surrounding tissues seem to be beneficial. The addition of RGD 
therefore resulted in enhanced soft tissue integration (Dahlin et al., 2014). 
By reducing the amount of CMC from 2.2% to 0% (PEG MD/RGD_LV), the hydrogel formulation 
becomes less viscous and the clinical handling is more difficult in terms of controlling the area, 
where the matrix/membrane is applied. In the present study, a framework was used to 
standardize the application of all PEG hydrogels. A reduction of the CMC content, however, 
reduced the membrane stability, which therefore limits PEG volume maintenance over time. In 
addition, it has been reported that CMC decreases osteoclastogenesis, whereas 
osteoblastogenesis remains unaffected (Agis et al., 2010). The effect of CMC on bone formation 
and remodeling could not be shown in the present study. 
The loosest network PEG LD/RGD was able to maintain the space for two weeks only. Thereafter, 
degradation started accompanied by a reduction of the membrane volume and a consecutive loss 
of PEG volume maintenance. With the beginning degradation at 2 weeks, one might assume that 
the cell occlusiveness will also be reduced. In contrast, the contact towards the surrounding soft 
tissues was very intimate already at 1 week similar to previously published data (Thoma et al., 
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2011). Nevertheless, successful and predictable bone regeneration can only be achieved through 
continuous space maintenance and cell occlusiveness. Therefore the loosest network PEG 
LD/RGD might not be an ideal candidate as a membrane, but rather serve as a matrix. 
The collagen membrane (BG) started with a lower percentage of residual membrane within the 
ROI compared to PEG hydrogel layers. This was due to the fact that the thickness of the BG 
could not be changed unlike for the PEG hydrogels. The favorable integration and intimate 
contact to the surrounding tissues was histologically visible during the entire observation period. 
The degradation process of the collagen membrane was accompanied by a visible ingrowth of 
connective tissue and a continuous integration into the surrounding tissues similar to a previous 
experiment (Ghanaati et al., 2011). This remains a main contrast compared to the PEG 
hydrogels, which are never infiltrated by cells. The hydrogels seem to be encapsulated until their 
complete degradation, and body’s own tissues take the maintained space thereafter. Earlier 
studies reported stronger signs of inflammation around PEG hydrogels compared to collagen 
membranes (Jung et al., 2009b). In general, only a limited number of inflammatory cells were 
detected close to the PEG matrices/membranes. 
Limitations of the study are predominantly due to i) the standardization of the thickness during 
surgery and, ii) the histological processing of the PEG hydrogels. Standardization of the 
matrix/membrane thickness was optimized using preformed templates compared to a previous 
study (Thoma et al., 2011). Varying viscosities of the PEG hydrogels still presented challenges. 
In addition, the thickness of the control native collagen membrane was smaller, but kept into 
account when performing the analyses and interpretation of the results. Moreover, similar to the 
previous study, the PEG hydrogels appeared to swell during the healing period. This in 
combination with the histologic processing led to some detachment from the surrounding soft 
tissues. 
The present study illustrates the potential of modifications of polyethylene glycol hydrogels. 
Volume maintenance as well as tissue integration can be regulated by changing the network 
density. In case of a looser network structure, the contact to the surrounding soft tissues was 
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more intimate. Clinically, one might speculate that this favorable biological tissue integration 
could result in a lower rate of early wound dehiscence. In addition, RGD improved the contact to 
the surrounding tissues and accelerated the degradation of the membrane/matrix. PEG MD/RGD 
appeared to have an optimal balance between PEG volume maintenance, hydrogel degradation 
and soft tissue integration.  
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Conclusions 
Chemical and/or physical modifications of PEG hydrogels predominantly influenced matrix 
stability, degradation time and integration into the surrounding soft and hard tissues. The 
medium-dense network PEG hydrogel (PEG MD/RGD) demonstrated an optimal balance between 
membrane stability, degradation time and tissue integration. This membrane could serve as a 
favorable candidate for a synthetic GBR membrane in the future. 
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Legends: Tables and Figures 
 
Table 1. Descriptive statistics (mean, standard deviation, median and interquartile range in %) 
of histomorphometric measurements within the region of interest by matrix/membrane and by 
time-point. SD = standard deviation; IQR = interquartile range; PEG HD = a dense network PEG 
hydrogel; PEG MD = a medium-dense network PEG hydrogel; PEG MD/RGD = a medium-dense 
network PEG hydrogel modified with RGD; PEG MD/RGD_LV = a medium-dense network PEG 
hydrogel modified with RGD without addition of CMC and according low viscosity; PEG LD/RGD 
= a loose network PEG hydrogel modified with RGD; BG = a collagen membrane 
 
Figure 1 (a-f). Clinical pictures of flap elevation (1a), creation of bony defects marked by 
reference pins (1b), followed by randomly assigned membrane application (1c-f). The treatments 
are the following (starting at the upper left, then clockwise): BG = a collagen membrane; PEG 
LD/RGD = a loose network PEG hydrogel modified with RGD; PEG MD = a medium-dense 
network PEG hydrogel; PEG MD/RGD = a medium-dense network PEG hydrogel modified with 
RGD; PEG HD = a dense network PEG hydrogel; PEG MD/RGD_LV = a medium-dense network 
PEG hydrogel modified with RGD without addition of CMC and according low viscosity 
 
Figure 2a. Region of interest (ROI) (green rectangle) containing the matrix/membrane (M) 
material and the surrounding connective tissue (CT) and the underlying bone (B). 
 
Figure 2b. PEG HD at 6 weeks: The hydrogel (M) is densely stained and shows no signs of 
degradation. Due to shrinkage and a delayed tissue integration, the matrix is surrounded by an 
empty space. B=bone; CT=connective tissue 
 
Figure 2c. PEG MD at 2 weeks: The medium dense hydrogel (M) is densely stained. The soft 
tissues are detached from the matrix’ surface. B=bone; CT=connective tissue 
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Figure 2d. PEG MD/RGD at 2 weeks: the matrix (M) demonstrates an intimate contact to the 
surrounding soft tissues. B=bone; CT=connective tissue 
 
Figure 2e. PEG LD/RGD at 1 week: The contact to the surrounding tissues is intimate at this 
time point. M= matrix/membrane; B=bone; CT=connective tissue 
 
Figure 2f. BG at 1 week: The collagen membrane (M) demonstrates an intimate contact towards 
the underlying bone. Bundles of collagen fibers representing the membranes network are densely 
stained and surrounded by non-mineralized tissue. B=bone; CT=connective tissue 
 
Figure 3. Membrane degradation over time measured in percentage by terms of residual 
membrane. The lines represent a linear smoother. PEG HD = a dense network PEG hydrogel; 
PEG MD = a medium-dense network PEG hydrogel; PEG MD/RGD = a medium-dense network 
PEG hydrogel modified with RGD; PEG MD/RGD_LV = a medium-dense network PEG hydrogel 
modified with RGD without addition of CMC and according low viscosity; PEG LD/RGD = a loose 
network PEG hydrogel modified with RGD; BG = a collagen membrane (BG) 
 
FOR THE APPENDIX: 
 
Appendix 1: Detailed statistical methods. 
 
Appendix 2: Overall§ effect of treatment, time and interaction between time and treatment. 
 
Appendix 3: Association between outcomes and treatments: (a) for membrane/matrix at 1 
week and 6 weeks and (b) for new bone at 1 week and 6 weeks. Associations are adjusted by 
the effect of animal (random effect) and position and side (fixed effects). The black square 
indicates the adjusted means and the whiskers the 95% confidence intervals. 
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Appendix 4: Sometimes, inflammatory cells can be found within the soft tissues next to PEG 
materials as seen in this illustration. 
 
Appendix 5: At higher magnification, new bone formation within the defect and an intimate 
contact of PEG and bone are visible (PEG HD at 6 weeks). 
 
Appendix 6: PEG HD, a high density network PEG hydrogel at 2 weeks. The attachment to the 
underlying bone (B) seems to be more favorable than towards the soft tissue (CT). Furthermore, 
this illustration indicates the problem of shrinkage of PEG materials during the histologic process, 
leaving an impression of its original shape in the soft tissue. 
 
Appendix 7: PEG MD RGD, a medium-dense network PEG hydrogel modified with RGD shows an 
intimate contact to the underlying bone (B) as well as to the connective tissue (CT) at 4 weeks. 
 
Appendix 8: At 4 weeks, PEG MD/RGD_LV, a medium-dense network PEG hydrogel modified 
with RGD without addition of CMC and according low viscosity shows already clear signs of 
degradation. An ingrowth of the connective tissue (CT) is visible. B=bone 
 
Appendix 9: At 4 weeks, PEG LD, a loose network PEG hydrogel is almost completely degraded. 
Newly formed bone (NB) is visible underneath the membrane. CT=connective tissue 
 
Appendix 10: Only remnants of the collagen membrane (BG) are visible at 6 weeks. Newly 
formed bone (NB) can be found underneath the membrane. CT=connective tissue 
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Table 1. Descriptive statistics (mean, standard deviation, median and interquartile range in %) for the histomorphometric measurements within the region of 
interest by treatment and time point 
Outcome  Membrane type 
Parameter 
 
Time point 
 1 week 2 weeks 4 weeks 6 weeks 
Connective 
Tissue 
 
BG n  6 6 6 4 
Mean ± SD  47.3 ± 32.0 44.8 ± 19.8 34.6 ± 17.1 19.8 ± 3.7 
Median (IQR)  37.5  (19.3, 76.7) 51.4 (35.2, 60.8) 37.2 (15.9, 48.6) 18.5 (17.6, 22.0) 
PEG LD/RGD n  6 5 6 5 
Mean ± SD  36.2 ± 17.3 33.8   ± 11.4 30.9 ± 18.8 21.3 ± 10.9 
Median (IQR)  30.2 (25.0, 41.5) 31.3 (29.5, 43.8) 27.9 (15.3, 38.3) 17.9 (12.6, 28.7) 
PEG MD n  7 6 6 4 
Mean ± SD  45.0 ± 20.0 37.1 ± 15.2 25.0 ± 16.1 33.3 ± 31.8 
Median (IQR)  46.0 (29.5, 68.8) 31.5 (25.0, 46.0) 27.8 (8.0, 36.4) 21.9 (15.2, 51.3) 
PEG MD/RGD n  5 7 7 5 
Mean ± SD  25.4 ± 10.7 41.6 ± 22.1 25.0 ± 13.0 24.5 ± 25.1 
Median (IQR)  31.8 (17.0, 33.0) 29.0 (19.3, 64.5) 25.6 (13.1, 35.8) 14.2 (12.1, 15.6) 
PEG 
MD/RGD_LV 
n  7 6 5 6 
Mean ± SD  47.7 ± 21.6 42.7 ± 17.6 24.3 ± 8.1 31.3 ± 13.5 
Median (IQR)  47.7 (25, 63.1) 42.0 (29.0, 58.9) 19.9 (19.3, 25.3) 34.3 (16.5, 42.0) 
PEG HD n  7 6 5 5 
Mean ± SD  32.3 ± 24.5 32.9 ± 22.5 26.9 ± 12.8 34.3 ± 24.2 
Median (IQR)  25.6 (9.1, 54.5) 30.4 (13.6, 35.8) 24.4 (18.5, 33.0) 25.0 (17.6, 59.7) 
Matrix/Membrane 
 
BG n  6 6 6 4 
Mean ± SD  23.7 ± 12.7 30.1 ± 19.2 14.0 ± 11.8 10.1 ± 11.4 
Median (IQR)  23.0 (18.2, 30.7) 36.4 (6.8, 42.0) 11.2 (4.5, 18.8) 7.2 (2.0, 18.1) 
PEG LD/RGD n  6 5 6 5 
Mean ± SD  30.8 ± 26.2 40.1 ± 23.9 24.1 ± 16.1 10.8 ± 10.8 
Median (IQR)  19.5 (14.2, 57.3) 44.9 (39.6, 55.1) 22.0 (11.9, 36.4) 6.8 (2.7, 21.0) 
PEG MD n  7 6 6 4 
Mean ± SD  37.7 ± 18.7 25.9 ± 14.2 34.4 ± 30.0 8.7 ± 11.1 
Median (IQR)  43.2 (17.0, 51.4) 23.9 (13.1, 37.5) 27.7 (16.2, 38.6) 4.8 (2.0, 15.3) 
PEG MD/RGD n  5 7 7 5 
Mean ± SD  57.0 ± 12.5 43.1 ± 20.3 17.6 ± 21.5 18.6 ± 12.6 
Median (IQR)  55.4 (47.7, 64.8) 40.9 (22.4, 62.5) 10.2 (4.0, 23.9) 14.2 (9.8, 24.4) 
PEG 
MD/RGD_LV 
n  7 6 5 6 
Mean ± SD  26.4 ± 11.0 44.8 ± 15.7 46.6 ± 25.6 9.8 ± 6.4 
Median (IQR)  22.1 (17.0, 36.3) 40.9 (33.5, 56.8) 54.2 (21.0, 62.2) 8.5 (5.7, 11.4) 
PEG HD n  7 6 5 5 
Mean ± SD  47.2 ± 21.9 47.7 ± 24.4 64.5 ± 14.0 36.5 ± 28.5 
Median (IQR)  59.7(21.0, 63.6) 46.0 (27.8, 59.7) 65.9 (59.9, 69.9) 23.3 (21.0, 49.8) 
New bone 
 
BG n  6 6 6 4 
Mean ± SD  0.6 ± 0.5 7.4 ± 5.8 3.0 ± 1.4 4.0 ± 3.3 
Median (IQR)  0.6 (0.3, 1.1) 8.5 (1.7, 12.5) 3.1 (2.6, 4.3) 3.4 (1.6, 6.5) 
PEG LD/RGD n  6 5 6 5 
Mean ± SD  0.9 ± 1.1 10.6 ± 21.4 2.8 ± 3.4 4.1  ± 6.3 
Median (IQR)  0.6 (0.0, 1.1 ) 0.6 (0, 3.7) 1.7 (0.6, 3.7) 1.7 (1.7, 1.7) 
PEG MD n  7 6 6 4 
Mean ± SD  0.3 ± 0.4 5.6 ± 8.7 3.3 ± 4.3 7.1 ± 8.4 
Median (IQR)  0.1 (0, 0.6) 2.3 (0.6, 5.7) 1.7 (0.6, 4.3) 3.3 (2.4, 11.8) 
PEG MD/RGD n  5 7 7 5 
Mean ± SD  0.3 ± 0.4 1.8 ± 3.1 1.4 ± 1.6 1.0 ± 1.3 
Median (IQR)  0 (0, 0.6) 0.6 (0, 2.3) 1.1 (0.2, 1.7) 0.6 (0.6, 0.9) 
PEG 
MD/RGD_LV 
n  7 6 5 6 
Mean ± SD  0.2 ± 0.3 1.2 ± 0.6 2.3 ± 3.4 5.3 ± 7.4 
Median (IQR)  0 (0, 0.6) 1.4 (0.8, 1.7) 1.1 (0, 2.0) 1.1 (0.3, 11.2) 
PEG HD n  7 6 5 5 
Mean ± SD  0.1 ± 0.2 0.8 ± 1.0 3.5 ± 5.1 4.2 ± 3.4 
Median (IQR)  0 (0, 0) 0.4 (0, 1.7) 1.1 (0.3, 3.7) 3.7 (2.1, 5.7) 
Old bone 
 
BG n  6 6 6 4 
Mean ± SD  0.1 ± 0.3 0.2 ± 0.3 0.1 ± 0.1 0.2 ± 0.3 
Median (IQR)  0.0 (0.0, 0.0) 0.0 (0.0, 0.6) 0.0 (0.0, 0.3) 0.1 (0.0, 0.4) 
PEG LD/RGD n  6 5 6 5 
Mean ± SD  0.1 ± 0.2 0.5 ± 1.0 0.1 ± 0.2 0.5 ± 0.9 
Median (IQR)  0.0 (0.0, 0.0) 0.0 (0.0, 0.1) 0.0 (0.0, 0.0) 0.0 (0.0, 0.3) 
PEG MD n  7 6 6 4 
Mean ± SD  0.6 ± 0.7 0.2 ± 0.5 0.2 ± 0.6 0.1 ± 0.1 
Median (IQR)  0.0 (0.0, 1.1) 0.0 (0.0, 0.0) 0.0 (0.0, 0.0) 0.0 (0.0, 0.1) 
PEG MD/RGD n  5 7 7 5 
Mean ± SD  0.2 ± 0.3 0.0 ± 0.1 0.2 ± 0.2 0.4 ± 0.6 
Median (IQR)  0.0 (0.0, 0.6) 0.0 (0.0, 0.0) 0.0 (0.0, 0.4) 0.0 (0.0, 0.4) 
PEG 
MD/RGD_LV 
n  7 6 5 6 
Mean ± SD  0.0 ± 0 0.3 ± 0.3 0.1 ± 0.3 0.0 ± 0.1 
Median (IQR)  0.0 (0.0, 0.0) 0.1 (0.0, 0.6) 0.0 (0.0, 0.0) 0.0 (0.0, 0.0) 
PEG HD n  7 6 5 5 
Mean ± SD  0.4 ± 1.1 0.3 ± 0.5 1.1 ± 2.1 0.2 ± 0.5 
Median (IQR)  0.0(0.0, 0.0) 0.0 (0.0, 0.4) 0.3  0.0, 0.6) 0.0 (0.0, 0.0) 
Background 
 
BG n  6 6 6 4 
Mean ± SD  28.3 ± 25.9 17.5 ± 20.8 48.2 ± 16.0 65.9 ± 9.4 
Median (IQR)  29.8 (4.0, 50.3) 9.9 (0.0, 42.0) 49.0 (34.1, 50.0) 67.3 (58.2, 73.6) 
PEG LD/RGD n  6 5 6 5 
Mean ± SD  32.1 ± 32.3 15.1 ± 13.3 42.1 ± 33.0 63.4 ± 5.7 
Median (IQR)  29.5 (0.0, 60.8) 13.6 (5.1, 15.9) 47.5 (5.9, 75.0) 62.8 (61.9, 68.2) 
PEG MD n  7 6 6 4 
Mean ± SD  16.4 ± 19.2 31.3 ± 26.2 37.0 ± 22.2 50.9 ± 28.0 
Median (IQR)  13.1 (4.5, 17.0) 34.1 (1.7, 55.7) 41.2 (27.0, 55.4) 54.3 (32.2, 69.5) 
PEG MD/RGD n  5 7 7 5 
Mean ± SD  17.1 ± 13.8 13.5 ± 9.4 55.9 ± 25.7 55.5 ± 25.1 
Median (IQR)  15.3 (8.9, 19.3) 12.5 (6.3, 18.8) 62.5 (51.1, 68.8) 58.0 (49.9, 74.8) 
PEG 
MD/RGD_LV 
n  7 6 5 6 
Mean ± SD  25.6 ± 21.9 11.0 ± 19.9 26.7 ± 26.5 53.6 ± 15.3 
Median (IQR)  23.01 (0.0, 39.2) 3.0 (0.0, 9.1) 10.8 (7.7, 53.1) 54.8 (48.3, 60.2) 
PEG HD n  7 6 5 5 
Mean ± SD  20.1 ± 14.4 18.4 ± 18.3 3.9 ± 4.3 24.8 ± 16.3 
Median (IQR)  26.1 (4.5, 31.3) 15.3 (2.3, 35.2) 3.1 (0.6, 4.8) 30.5 (9.1, 30.7) 
SD = standard deviation; IRQ = interquartile range; PEG HD = a dense network PEG hydrogel; PEG MD = a medium-dense network PEG hydrogel; PEG 
MD/RGD = a medium-dense network PEG hydrogel modified with RGD; PEG MD/RGD_LV = a medium-dense network PEG hydrogel modified with RGD without 
addition of CMC and according low viscosity; PEG LD/RGD = a loose network PEG hydrogel modified with RGD; BG = a collagen membrane 
 
Appendix 1 
 
 
Statistical analysis: 
All measured outcomes were summarized as means and standard deviations, and as 
medians and interquartile ranges. Comparisons between treatment modalities were first 
examined pairwise using the Wilcoxon signed rank test (results not shown). To account 
for the effect of factors such as animal, position of the defect on the skull and side on 
the respective comparisons of the treatments, mixed linear models were carried out for 
each time point. The factor animal was added to the model as a random effect, position 
and side as fixed effects. The mixed linear models were performed using the non-
parametric Brunner-Langer method (Brunner & Langer 1999). Global comparisons 
(Brunner-Langer, F1_LD_F1 model) of the effects of treatment and time points on each 
of the outcomes were examined first and then the calculated effects resulting from the 
above models were adjusted for multiple comparisons using Dunnett-Hsu’s correction 
(Brunner 2010). The calculated effects (the least square means and 95%CI of the 
ranked outcome for each of the levels of the categorical variables were extracted and 
back transformed to the scale of the original outcome variable) are expressed as 
adjusted ‘means’ in the results. The level of significance was set at p<0.05. SAS release 
9.4 (SAS Institute Inc, 2002-2012, Cary, NC, USA) was used for the statistical analysis. 
 
Brunner, E. (2010) SAS standard procedures for the analysis of non-parametric data. (in 
German). http://saswiki.org/images/e/e3/5.KSFE-2001-brunner-Einsatz-von-SAS-Modulen-
f%C3%BCr-die-nichtparametrische-Auswertung-von-longitudinalen-Daten.pdf. 
Brunner, E. & Langer, F. (1999) Non-parametric analysis of longitudinal data. (in German).  
Oldenburgverlag, Munich. 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix 2 
 
Overall§ effect of treatment, time and interaction between time and treatment. Outcome		 Parameter	 p-Value*	Connective	tissue	(%)	 Treatment	 0.623		 Time	point	 0.005		 Treatment	*	Time	point	 0.952	Matrix/Membrane	(%)	 Treatment	 <0.001		 Time	point	 <0.001		 Treatment	*	Time	point	 0.033	New	bone	(%)	 Treatment	 0.016		 Time	point	 <0.001		 Treatment	*	Time	point	 0.872	Old	bone	(%)	 Treatment	 0.940		 Time	point	 0.914		 Treatment	*	Time	point	 0.742	Background		(%)	 Treatment	 0.005		 Time	point	 <0.0001		 Treatment	*	Time	point	 0.146	
* Type 3 tests of fixed effects (treatment and time). The effect of an animal was 
introduced in the model as random effect, 
§ Global comparisons done using Brunner-Langer, F1_LD_F1 model 
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